Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma
- PMID: 20730866
- DOI: 10.1002/ar.21217
Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma
Abstract
Bladder cancer is frequently associated with regional lymph node metastasis at the time of diagnosis or after initial treatment, and lymph node metastasis is crucial for clinical therapeutic strategies. Lymphangiogenesis, detected by antibodies specific for lymphatic endothelial cells, is correlated with cancer spread, but the mechanisms that underlie lymphatic spread and the role of lymphangiogenesis in cancer metastasis has been less clear. The aim of this study was to investigate the association of vascular endothelial growth factor (VEGF)-D expression, intratumoral lymphatics, and lymphatic invasion associated with lymph node metastasis as well as the prognostic analysis in patients with bladder transitional cell carcinoma (TCC). The VEGF-D expression was evaluated by immunohistochemistry in 72 specimens, and tumoral lymphatic vessels were measured by D2-40. Counts of lymph vessels were taken in intratumoral and peritumoral areas. Survival analyses and their independent roles were investigated using univariate and multivariate analysis models. The high expression of VEGF-D was closely associated with the intratumoral lymphatic vessels, tumoral lymphatic invasion, and lymph node metastasis as well as a shorter overall survival. Higher lymphatic vessel density, intratumoral lymphatics, and lymphatic invasion showed a significant association with lymph node metastasis. Univariate analysis indicated that VEGF-D, intratumoral lymphatics, and lymphatic invasion were associated with overall survival, but they were not independent prognostic factors for bladder TCC in multivariate analysis. We conclude that VEGF-D plays an essential role in tumoral lymphangiogenesis. Intratumoral lymphatics and lymphatic invasion are important predictive factors of pelvic lymph node metastasis in patients with bladder cancer.
Similar articles
-
Vascular endothelial growth factor D and intratumoral lymphatics as independent prognostic factors in epithelial ovarian carcinoma.Anat Rec (Hoboken). 2009 Apr;292(4):562-9. doi: 10.1002/ar.20845. Anat Rec (Hoboken). 2009. PMID: 19226617
-
Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.Int J Urol. 2005 Feb;12(2):152-8. doi: 10.1111/j.1442-2042.2005.01010.x. Int J Urol. 2005. PMID: 15733109
-
[New markers for pharmacological targeting in bladder cancer with lymph node metastasis].Aktuelle Urol. 2007 Sep;38(5):392-7. doi: 10.1055/s-2007-980110. Aktuelle Urol. 2007. PMID: 17907066 German.
-
Molecular control of lymphatic metastasis.Ann N Y Acad Sci. 2008;1131:225-34. doi: 10.1196/annals.1413.020. Ann N Y Acad Sci. 2008. PMID: 18519975 Review.
-
[The importance of lymphadenectomy for muscle invasive transitional cell carcinoma of the human bladder - a review of the literature].Aktuelle Urol. 2011 Mar;42(2):115-21. doi: 10.1055/s-0031-1271411. Epub 2011 Mar 24. Aktuelle Urol. 2011. PMID: 21437835 Review. German.
Cited by
-
Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer.Int J Clin Oncol. 2018 Jun;23(3):532-538. doi: 10.1007/s10147-017-1227-6. Epub 2017 Dec 23. Int J Clin Oncol. 2018. PMID: 29275449
-
CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.Int J Oncol. 2017 Jul;51(1):75-90. doi: 10.3892/ijo.2017.4003. Epub 2017 May 17. Int J Oncol. 2017. PMID: 28534984 Free PMC article.
-
Communication Of Cancer Cells And Lymphatic Vessels In Cancer: Focus On Bladder Cancer.Onco Targets Ther. 2019 Oct 3;12:8161-8177. doi: 10.2147/OTT.S219111. eCollection 2019. Onco Targets Ther. 2019. PMID: 31632067 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical